Lakewood-Amedex Biotherapeutics Inc. SEC filings LABT

Lakewood-Amedex Biotherapeutics Inc. has 44 filings in SEC EDGAR's recent list, going back to Jul 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (shareholder vote results). The company's fiscal year ends on December 31.

Form Description Filed Period
S-1 Registration statement Sep 18, 2026 —
424B3 Prospectus Aug 17, 2026 —
424B3 Prospectus Jun 22, 2026 —
424B3 Prospectus Jun 22, 2026 —
424B3 Prospectus May 26, 2026 —
424B3 Prospectus May 26, 2026 —
424B4 Prospectus May 14, 2026 —
S-1 Registration statement May 1, 2026 —
424B3 Prospectus Apr 30, 2026 —
424B4 Prospectus Apr 23, 2026 —
S-1/A Amended registration statement Apr 6, 2026 —
S-1/A Amended registration statement Apr 1, 2026 —
S-1/A Amended registration statement Mar 11, 2026 —
S-1/A Amended registration statement Feb 13, 2026 —
S-1/A Amended registration statement Feb 5, 2026 —
S-1 Registration statement Jan 9, 2026 —

Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LABT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
University Park, FL
SEC filer status
, Emerging growth company
SEC CIK
2079272

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.